PCORI is now accepting Letters of Intent (LOI) under two reopened targeted PCORI Funding Announcements (PFAs). In one, PCORI is offering up to $30 million for studies comparing two or more strategies to treat multiple sclerosis (MS), focusing on therapeutic effects, quality of life, and functional status. In the other, PCORI is offering up to $19 million for studies of clinical strategies for managing and reducing long-term opioid use.
LOIs are due Tuesday, Nov. 1.